Oracle, Vertiv And A Health Care Stock On CNBC's 'Final Trades'
Oracle, Vertiv And A Health Care Stock On CNBC's 'Final Trades'
On Oct. 23, Vertiv reported third-quarter results. Net sales rose 19% year-over-year to $2.074 billion, beating the consensus of $1.977 billion. Organic orders (excluding foreign exchange) rose 17%. Adjusted operating profit surged 41% to $417 million, with the On CNBC's "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said Oracle Corporation (NYSE:ORCL) is going to report a strong quarter and recommended staying long on the stock.
在CNBC的《半場報告最終交易》中，odyssey資本顧問的傑森·斯奈普表示，甲骨文公司（紐交所：ORCL）即將公佈強勁的季度業績，並建議繼續開多這隻股票。
Oracle is scheduled to release quarterly earnings after the closing bell today. Analysts expect the company to post quarterly earnings at $1.48 per share on revenue of $14.11 billion.
甲骨文公司預計將在今天收盤後發佈季度收益。分析師預計該公司的季度每股收益爲1.48美元，營業收入達141.1億。
Stephen Weiss of Short Hills Capital Partners named Vertiv Holdings Co (NYSE:VRT) as his final trade.
Short Hills Capital Partners 的 Stephen Weiss 將 vertiv holdings 公司 (紐交所: VRT) 選爲他的最後交易。
On Oct. 23, Vertiv reported third-quarter results. Net sales rose 19% year-over-year to $2.074 billion, beating the consensus of $1.977 billion. Organic orders (excluding foreign exchange) rose 17%. Adjusted operating profit surged 41% to $417 million, with the margin expanding 310 basis points to 20.1%, driven by higher volumes and favorable commercial execution.
10月23日，Vertiv發佈了第三季度業績。淨銷售額同比增長19%，達到20.74億，超出預期的19.77億。剔除匯率影響後的有機訂單增長17%。調整後的營業利潤激增41%，達到41700萬，毛利率擴大310個點子至20.1%，主要受更高的銷量和有利的商業執行驅動。
Don't forget to check out our premarket coverage here
別忘了查看我們的盤前報道。
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC said GSK plc (NASDAQ:GSK) has a 4.5% dividend yield.
Gilman Hill 資產管理公司（LLC）的Jenny Van Leeuwen Harrington表示，GSk plc（納斯達克：GSK）的股息收益率爲4.5%。
On Nov. 19, GSK released the headline results of the GLISTEN global phase 3 trial evaluating linerixibat in adults with cholestatic pruritus (relentless itch) associated with primary biliary cholangitis (PBC), a rare autoimmune liver disease. GLISTEN met its primary endpoint, with linerixibat improving itch, as demonstrated by a statistically significant reduction from baseline in monthly itch score over 24 weeks versus placebo.
11月19日，GSk發佈了評估linerixibat在患有與原發性膽汁性膽管炎（PBC）相關的膽汁性瘙癢（持續性瘙癢）的成年人中進行的GLISTEN全球第三階段試驗的標題結果。GLISTEN達到了其主要終點，linerixibat改善瘙癢，顯示在24周內與安慰劑相比，其月度瘙癢評分從基線顯著減少。
Price Action:
價格行動：
- Oracle shares gained by 2.9% to close at $191.69 on Friday.
- Vertiv shares fell by 0.5% to settle at $133.85 during Friday's session.
- GSK shares gained by 0.1% to close at $34.57 on Friday.
- 甲骨文的分享在週五上漲了2.9%，收於191.69美元。
- Vertiv的分享在週五的交易中下跌了0.5%，收於133.85美元。
- GSk的分享在週五上漲了0.1%，收於34.57美元。
- How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings
- 如何在第二季度業績前從甲骨文股票中每月賺取500美元
Image: Shutterstock
圖片：shutterstock
